Vascular risk and Aβ interact to reduce cortical thickness in AD vulnerable brain regions.
about
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkersStructural imaging measures of brain aging.Anatomical, functional and molecular biomarker applications of magnetic resonance neuroimaging.Impact of Alzheimer's Disease, Lewy Body and Vascular Co-Pathologies on Clinical Transition to Dementia in a National Autopsy CohortThe potential applications of Apolipoprotein E in personalized medicineStroke risk interacts with Alzheimer's disease biomarkers on brain aging outcomes.Are AD-Typical Regions the Convergence Point of Multiple Pathologies?Cooccurrence of vascular risk factors and late-life white-matter integrity changes.Humic Acid Increases Amyloid β-Induced Cytotoxicity by Induction of ER Stress in Human SK-N-MC Neuronal CellsAge Differences in Prefrontal Surface Area and Thickness in Middle Aged to Older Adults.The neuropathology and cerebrovascular mechanisms of dementiaβ-amyloid, hippocampal atrophy and their relation to longitudinal brain change in cognitively normal individuals.Impact of lifestyle dimensions on brain pathology and cognition.Glucose Dysregulation Interacts With APOE-∊4 to Potentiate Temporoparietal Cortical ThinningCerebral β-Amyloid Angiopathy Is Associated with Earlier Dementia Onset in Alzheimer's DiseaseTau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.Aβ mediates Sigma receptor degradation via CaN/NFAT pathwayCoronary artery calcium is associated with cortical thinning in cognitively normal individuals.Plasma Cystatin C and High-Density Lipoprotein Are Important Biomarkers of Alzheimer's Disease and Vascular Dementia: A Cross-Sectional Study.A T1 and DTI fused 3D corpus callosum analysis in MCI subjects with high and low cardiovascular risk profile.A major role for cardiovascular burden in age-related cognitive decline.Gray matter structural networks are associated with cardiovascular risk factors in healthy older adults.Impact of multiple pathologies on the threshold for clinically overt dementia.APOEε4 Genotype and Hypertension Modify 8-year Cortical Thinning: Five Occasion Evidence from the Seattle Longitudinal Study.Total Brain and Hippocampal Volumes and Cognition in Older American Indians: The Strong Heart Study.Anti-Inflammatory and Neuroprotective Effects of Co-UltraPEALut in a Mouse Model of Vascular Dementia.Imaging Vascular Disease and Amyloid in the Aging Brain: Implications for TreatmentAge, vascular health, and Alzheimer disease biomarkers in an elderly sample.Excessive daytime sleepiness and fatigue may indicate accelerated brain aging in cognitively normal late middle-aged and older adults.White Matter Hyperintensities Potentiate Hippocampal Volume Reduction in Non-Demented Older Individuals with Abnormal Amyloid-β.Distinctive Resting State Network Disruptions Among Alzheimer's Disease, Subcortical Vascular Dementia, and Mixed Dementia Patients.Proximity to Parental Symptom Onset and Amyloid-β Burden in Sporadic Alzheimer Disease.The Dose-Dependent Effects of Vascular Risk Factors on Dynamic Compensatory Neural Processes in Mild Cognitive Impairment.Assessment of Extent and Role of Tau in Subcortical Vascular Cognitive Impairment Using 18F-AV1451 Positron Emission Tomography Imaging
P2860
Q26745508-4E78FCE6-4865-4C93-86FE-99C0AE28019FQ30844186-3AD97D59-797E-4B1E-9FCA-D4B2D5766559Q30910766-0DB81899-3FAC-433E-BA9D-EEAD7A5F6327Q33748421-BADEBAC2-EFD0-46D1-B118-F1B88D8908ABQ33858831-66DD9772-F4B4-4FF7-AEBD-951414282405Q34482685-F64E71F2-6E93-4B96-A3B2-89B722B6E4AEQ35216192-4EB36504-2823-4B9B-8C62-B1A2BA7D6BC7Q35236199-08CFCFBD-DAD7-4583-BCD2-DEC76538F2F7Q35723350-C6F7B721-91FC-4611-BA1F-BD05FC5A03FDQ36475313-E330DBCB-F952-4A8A-956E-E8A44CBA57EFQ36593201-D3FBAB9A-2EAD-499F-BF8E-87E0844CBFF3Q36687792-B26ABE77-44A3-4D3F-A275-D70F15DD7CBFQ36687806-8BCF8CF3-CDB2-4080-BCE4-2ED74DEE16C8Q37019867-71BCB302-496F-42F3-8374-63AD63F61CE2Q37025036-1A75E441-2A44-49BA-B75E-972E983B436BQ37220632-73B08ED9-65B5-447B-8E73-C131DD36D4C4Q37227991-636ABB9D-87E8-4583-BCB1-BE3F8E9A9504Q37303653-011C4EE7-241B-496F-8159-650980191A5EQ37628115-790CCDA6-A9D4-4F57-A765-01ADAD851305Q37633191-11458113-3DAB-4EC2-ACE2-096716E8E4B0Q38316448-BD3D2B84-8E96-4F7A-8739-918050520175Q38600419-6609A3B8-3824-4B83-A23E-5BE57CDB9593Q38794960-1E6ADFD1-7C4B-4B00-8475-2F103A4C2B6DQ38819201-5116F5B4-9D88-4C2D-9F31-46058A332126Q40188198-684D712C-BA5A-4AFE-ACA3-655EB3FA712BQ42220056-873CC37A-7909-40EC-B64D-0B82799631E0Q42653687-D6C7A692-9E0A-4C6B-9121-1720101A70AEQ47653348-7A5E5A18-39A2-4957-9DAB-C2C2D77C68F5Q47776679-89A5C9DF-9DE1-4C93-B1D6-49C457FB03E0Q47930258-AEC164B8-155F-41A9-91BE-E64F4D4E1052Q49012669-5A296624-FD0B-48B9-928A-13D2C41DA4F4Q52684786-6E34E459-0DD4-4731-9D07-465952462710Q55002611-3A0BE2E7-F827-4C7B-BC12-4677DE666B96Q57214180-7B8883B8-0AA9-4853-9100-7FE101FE4EBC
P2860
Vascular risk and Aβ interact to reduce cortical thickness in AD vulnerable brain regions.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Vascular risk and Aβ interact ...... n AD vulnerable brain regions.
@ast
Vascular risk and Aβ interact ...... n AD vulnerable brain regions.
@en
type
label
Vascular risk and Aβ interact ...... n AD vulnerable brain regions.
@ast
Vascular risk and Aβ interact ...... n AD vulnerable brain regions.
@en
prefLabel
Vascular risk and Aβ interact ...... n AD vulnerable brain regions.
@ast
Vascular risk and Aβ interact ...... n AD vulnerable brain regions.
@en
P2093
P2860
P50
P1433
P1476
Vascular risk and Aβ interact ...... n AD vulnerable brain regions.
@en
P2093
Bruce R Reed
Cindee M Madison
Helena C Chui
Miranka Wirth
Nerses Sanossian
Stephen Kriger
Sylvia Villeneuve
Wendy J Mack
William J Jagust
P2860
P356
10.1212/WNL.0000000000000550
P407
P577
2014-06-06T00:00:00Z